The yield of SNP microarray analysis for fetal ultrasound cardiac abnormalities
- PMID: 38580914
- PMCID: PMC10998306
- DOI: 10.1186/s12884-024-06428-9
The yield of SNP microarray analysis for fetal ultrasound cardiac abnormalities
Abstract
Background: Chromosomal microarray analysis (CMA) has emerged as a critical instrument in prenatal diagnostic procedures, notably in assessing congenital heart diseases (CHD). Nonetheless, current research focuses solely on CHD, overlooking the necessity for thorough comparative investigations encompassing fetuses with varied structural abnormalities or those without apparent structural anomalies.
Objective: This study sought to assess the relation of single nucleotide polymorphism-based chromosomal microarray analysis (SNP-based CMA) in identifying the underlying causes of fetal cardiac ultrasound abnormalities.
Methods: A total of 2092 pregnant women who underwent prenatal diagnosis from 2017 to 2022 were included in the study and divided into four groups based on the presence of ultrasound structural abnormalities and the specific type of abnormality. The results of the SNP-Array test conducted on amniotic fluid samples from these groups were analyzed.
Results: Findings from the study revealed that the non-isolated CHD group exhibited the highest incidence of aneuploidy, overall chromosomal abnormalities, and trisomy 18, demonstrating statistically significant differences from the other groups (p < 0.001). Regarding the distribution frequency of copy number variation (CNV) segment size, no statistically significant distinctions were observed between the isolated CHD group and the non-isolated CHD group (p > 0.05). The occurrence rates of 22q11.2 and 15q11.2 were also not statistically different between the isolated CHD group and the non-isolated congenital heart defect group (p > 0.05).
Conclusion: SNP-based CMA enhances the capacity to detect abnormal CNVs in CHD fetuses, offering valuable insights for diagnosing chromosomal etiology and facilitating genetic counseling. This research contributes to the broader understanding of the utility of SNP-based CMA in the context of fetal cardiac ultrasound abnormalities.
Keywords: Congenital heart disease; Copy number variation; Prenatal diagnosis; Single nucleotide polymorphism microarray.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Comprehensive evaluation of genetic variants using chromosomal microarray analysis and exome sequencing in fetuses with congenital heart defect.Ultrasound Obstet Gynecol. 2021 Sep;58(3):377-387. doi: 10.1002/uog.23532. Ultrasound Obstet Gynecol. 2021. PMID: 33142350
-
Clinical features and genetic analysis of 471 cases of fetal congenital heart disease.BMC Pregnancy Childbirth. 2024 Nov 25;24(1):780. doi: 10.1186/s12884-024-06978-y. BMC Pregnancy Childbirth. 2024. PMID: 39587524 Free PMC article.
-
Identification of copy number variations associated with congenital heart disease by chromosomal microarray analysis and next-generation sequencing.Prenat Diagn. 2016 Apr;36(4):321-7. doi: 10.1002/pd.4782. Epub 2016 Mar 8. Prenat Diagn. 2016. PMID: 26833920 Clinical Trial.
-
Chromosomal abnormalities in fetuses with congenital heart disease: a meta-analysis.Arch Gynecol Obstet. 2023 Sep;308(3):797-811. doi: 10.1007/s00404-023-06910-3. Epub 2023 Jan 7. Arch Gynecol Obstet. 2023. PMID: 36609702 Review.
-
Application of next-generation sequencing for the diagnosis of fetuses with congenital heart defects.Curr Opin Obstet Gynecol. 2019 Apr;31(2):132-138. doi: 10.1097/GCO.0000000000000520. Curr Opin Obstet Gynecol. 2019. PMID: 30608255 Review.
References
-
- Global Burden of Disease. Study C. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the global burden of Disease Study 2013. Lancet. 2015;386(9995):743–800. doi: 10.1016/S0140-6736(15)60692-4. - DOI - PMC - PubMed
-
- Wang H, Lin X, Lyu G, He S, Dong B, Yang Y. Chromosomal abnormalities in fetuses with congenital heart disease: a meta-analysis. Arch Gynecol Obstet 2023, 1–15. - PubMed
-
- Rachamadugu SI, Miller KA, Lee IH, Zou YS. Genetic detection of congenital heart disease. Gynecol Obstet Clin Med 2022.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical